Milad Alucozai is the Head of Bio and Deep Tech at BoxOne Ventures. He is also a Venture Partner at Entrepreneur First, a global fund with a portfolio value of over $5 billion.
Milad began his career as a bench scientist working in translational neuroscience and multiphysics labs and transitioned into founding roles at multiple healthcare and bio startups. During his time at Accenture, Milad led data scientists, designers, and engineers focused on building AI products for global pharmaceutical companies and hospital networks. He has also served as an advisor to startups
like Numerate, a San Francisco-based drug discovery company (acquired by Valo Health), and Absci, a Vancouver-based AI-powered synthetic biology company that recently went public.
Milad is a former Visiting Scholar in Healthcare Engineering at the Regenstrief Center. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine and graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed graduate school in Immunology & Public Health.